Elocon Topical Ointment 0.1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Elocon: Topical ointment (0.1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MOMETASONE (moe MET a sone) is a corticosteroid. It is used to treat skin problems that may cause itching, redness, and swelling.

In-Depth Information

Elocon 0.1% Topical Ointment

NDC: 000850370
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Contact Dermatitis, Keloids, Alopecia, Rhus Dermatitis, Necrobiosis Lipoidica Diabeticorum, Eczema, Pemphigus, Sarcoidosis, Discoid Lupus Erythematosus, Granuloma Annulare, Seborrheic Dermatitis, Polymorphous Light Eruption, Pruritus, Pityriasis Rosea, Psoriasis, Lichen Striatus, Atopic Dermatitis, Lichen Planus, Xerosis, Exfoliative Dermatitis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Elocon 0.1% Topical Ointment

Reported Side Effects for Elocon 0.1% Topical Ointment

Infection Incidence:
<15.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
0.5-1.5%*
Severity: MILD
Onset: RAPID
Dry Mouth Incidence:
1.0-2.9%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
4.0-22.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Elocon

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.